Procoagulants and hemophilia drugs Flashcards
2 types of hemophilia
A and B
A is a deficiency in factor VIII
B is a deficiency in factor IX (Christmas factor)
Hemophilia tx
Replacing clotting factors
Severity of hemophilia depends on how much clotting factor is lacking
Hemophilia drugs
Desmospressin - releases factor VIII from endothelium. Does not release IX therefore only for A
Aminocaproic acid - antifibrinolytic agent which works by inhibition of plasminogen activators
Hemophilia and NSAIDS
Pts should avoid ASA as they suppress platelet aggregation and promote GI ulceration and bleeding
Second gen NSAIDS (COX 2 inhibitors) are considered to be safer
TXA inhibits
Plasmin (the enzyme that dissolves the fibrin meshwork of blood clots)
TXA binds to lysine receptor sites on plasmin and prevents plasmin from binding to lysine molecules in fibrin
TXA class TRANexamic acid
Antifibrinolytic for traumatic hemorrhage
TXA contras
Hyper sensitivity, thromboembolic disease (DVT, CVA, PE)
Injury over 3 hours
TXA criteria
Traumatic injury under 3 hours ago with a pt over 16, pressure under 90 or heart rate over 110
TXA dose
1g IV/IO in 250mL D5W or NS over 10 minutes (10gtts = 4 per second) no repeat
Hemophilia is seen in
males mostly. 70% from defective gene from mama, 30% from spontaneous gene mutation
Hemophilia A deficiency in
VIII (antihemophilic factor)
Hemophilia B deficiency in
IX (Christmas factor) A is 6X more prevalent than B.
1 in 5000 to 1 in 30000 males
Patho of hemophilia
Platelet aggregation is normal, but fibrin production is inhibited.
VIII and IX are part of contact (intrinsic) activation coagulation pathway and are needed to catalyze X to Xa which in turn catalyzes prothrombin to thrombin.
Desmporessin
Analog of ADH. Works be releasing stored factor VIII from vascular endothelium. Good for mild hemophilia A.
Antifibrinolytic Agents
Most useful for preventing recurrent bleeding less useful for stopping ongoing bleed.
Aminocaproic acid and TXA